May. 7 at 7:02 PM
$QNTM just doubled its liquidity — and the biotech pipeline is still moving full speed 🚀
💰 Cash, cash equivalents + digital assets jumped to
$9.8M in Q1, up from
$4.1M at year-end
📉 Operating cash burn dropped 60% YoY after Phase 1 trial completion
🧬 Lucid-MS IND officially submitted to the FDA, with Phase 2 plans advancing alongside Allucent
Meanwhile, management says current liquidity could fund operations through approximately July 2027.
See what Wall Street expects next 👉
https://www.zacks.com/stock/research/QNTM/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-38021&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_38021